×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Biopharma Layoff Tracker 2024: Ginkgo, Marinus, Kenvue and More Cut Staff
BioSpace
Follow along as BioSpace keeps you up-to-date on the latest pharma and biotech layoffs.
2 hours ago
Man accused of insider trading tied to Pfizer's Array purchase
Fierce Biotech
A man is facing criminal and civil cases for alleged insider trading after apparently learning from his wife that Pfizer may acquire Array...
6 months ago
End of Boulder R&D operations for Pfizer in Boulder
9News
BOULDER, Colo. — Biopharmaceutical giant Pfizer says it plans to shutter its Boulder research and development operations by mid-year,...
3 weeks ago
FDA OKs Drug Combo in BRAF V600E-Mutated Metastatic NSCLC
Medscape
The US Food and Drug Administration (FDA) has approved encorafenib (Braftovi, Pfizer) with binimetinib (Mektovi, Array BioPharma) for adults...
7 months ago
Pfizer to shutter Boulder R&D operations – BizWest
BizWest
Pfizer Inc. will shut down its research and development facility in Boulder in the coming months and lay off workers.
3 weeks ago
Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round ...
The Business Journals
Founder of multibillion-dollar drug developer Array BioPharma leads Boulder oncology startup in $54M financing round. The raise this week...
11 months ago
Array Technologies, Inc. (ARRY) is a Top-Ranked Value Stock: Should You Buy?
Yahoo Finance
For new and old investors, taking full advantage of the stock market and investing with confidence are common goals.
3 months ago
Array played with Pfizer's eagerness to land a deal on time—and got itself a better offer
Fierce Pharma
When it comes to buying an experienced cancer drug specialist, a bidding war is naturally expected. But in the case of Pfizer's $11 billion...
58 months ago
Pfizer bolsters its cancer portfolio with a $10.64 billion deal for Array
CNBC
Pfizer is acquiring Array Biopharma for $10.64 billion in cash. The deal will give Pfizer access to Array's approved drugs for skin cancer...
58 months ago
Strengthening Pfizer's R&D Engine and Oncology Leadership Through Acquisition of Array BioPharma
Pfizer
Array became known for its scientific acumen and nimble culture. This acquisition brought exceptional talent to Pfizer, as well as an impressive and broad...
50 months ago